The dominant force today is a sharp sector bifurcation. IT's 4.23% single-session surge has done the heavy lifting for index-level gains, masking broad-market softness in pharma and selective consumer names. That leadership is credible while dollar index stays depressed near 99.1 — a zone that has historically kept rupee-denominated export margins elevated — but it narrows the breadth of any sustained advance.

The floor is being maintained by domestic institutions, with DII cash inflows of 5,109 Cr on T-1 more than absorbing FII selling of 3,912 Cr for a net positive 1,197 Cr. VIX collapsing 7.42% to 15.32 signals that options writers are comfortable selling premium, which is a quiet but meaningful vote of confidence in range stability. Max-pain at 23,500 keeps expiry gravity close to current spot levels.

The rotation story worth watching is crude-exposed versus crude-insulated. Brent re-crossing $93 redirects margin pressure onto OMCs, aviation, and paint names while simultaneously making defensives like IT and select pharma more attractive on a relative basis. The RBI's VRR auction today also warrants attention as a read on near-term liquidity management intent.